PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Lecithin→

Lecithin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
620098-18-2
Molecular formula
C42H80NO8P
Molecular weight
758.1 g/mol
Drug class
Phospholipid mixturepharmaceutical emulsifier, solubiliser and excipient
Mechanism of action
Amphiphilic phospholipids organise at oil-water interfaces and form emulsions or lipid structures. This is a formulation function rather than a defined systemic pharmacological mechanism.
Indications / reported uses
  • Used as an emulsifier, stabiliser, solubiliser or lipid component in pharmaceutical and nutritional formulations; lecithin itself does not have a single therapeutic indication.

Sources: https://doi.usp.org/USPNF/USPNF_M44420_03_01.html · https://doi.usp.org/USPFCC/FCC_F100404_07_01.html · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Lecithin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Lecithin Permitted Daily Exposure (PDE) report (the Lecithin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Lecithin Occupational Exposure Limit (OEL) report (the Lecithin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.